These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Highly Sensitized Patients: Miami Transplant Institute Experience. Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R. Clin Transpl; 2014 Sep; ():171-8. PubMed ID: 26281142 [Abstract] [Full Text] [Related]
31. Detailed examination of HLA antibody development on renal allograft failure and function. Zhu L, Lee PC, Everly MJ, Terasaki PI. Clin Transpl; 2008 Sep; ():171-87. PubMed ID: 19711514 [Abstract] [Full Text] [Related]
32. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations. Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL. Transpl Int; 2014 Jan; 27(1):60-8. PubMed ID: 24131087 [Abstract] [Full Text] [Related]
33. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA. Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633 [Abstract] [Full Text] [Related]
34. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies. Chen Y, Li LY, Lou XY, Wang H, Zhang L, Zhu YH. Clin Transpl; 2014 Mar; ():205-8. PubMed ID: 26281146 [Abstract] [Full Text] [Related]
37. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM. Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671 [Abstract] [Full Text] [Related]
38. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G, Collaborative Transplant Study Report. Transplantation; 2015 Sep 01; 99(9):1976-80. PubMed ID: 25769065 [Abstract] [Full Text] [Related]
39. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Aubert V, Venetz JP, Pantaleo G, Pascual M. Hum Immunol; 2009 Aug 01; 70(8):580-3. PubMed ID: 19375474 [Abstract] [Full Text] [Related]
40. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation. Lee HS, Kim MS, Kim YS, Joo DJ, Ju MK, Kim SJ, Kim SI, Huh KH, Park K. Transplant Proc; 2012 Jan 01; 44(1):273-5. PubMed ID: 22310631 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]